Phase II trial of pirarubicin in epidermoid carcinoma of the head and neck.
Cappelaere
P
P
Centre Oscar Lambret, Lille, France.
Guiochet
N
N
Chauvergne
J
J
Bastit
P
P
Armand
J P
JP
Lentz
M A
MA
Van Glabbeke
M
M
Herait
P
P
Fumoleau
P
P
D000328:Adult; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000556:secondary; D004317:Doxorubicin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged
D004317:Doxorubicin; C027260:pirarubicin